메뉴 건너뛰기
British Journal of Dermatology
Volumn 163, Issue 5, 2010, Pages 1122-
Primary varicella-zoster infection in patients on biologic therapies for psoriasis
Author keywords

Biologics; Immunization; Tumour necrosis factor; VZV
Indexed keywords

ADALIMUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VIRUS ANTIGEN;
EID: 78249231417     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09938.x     Document Type: Letter
Times cited : (3)
References (9)
  • 1
    • 71949087471 scopus 로고    scopus 로고
    • British Association of Dermatologists guidelines for biologic interventions for psoriasis 2009
    • Smith CH, Anstey AV, Barker JNWN, et al. British Association of Dermatologists guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 987 -1019.
    • (2009) Br J Dermatol , vol.161 , pp. 987-1019
    • Smith, C.H.1    Anstey, A.V.2    Barker, J.3
  • 2
    • 0025810182 scopus 로고
    • Effects of tumour necrosis factor alpha on replication of varicella-zoster virus
    • Ito M, Nakano T, Kamiya T, et al. Effects of tumour necrosis factor alpha on replication of varicella-zoster virus. Antiviral Res 1991; 15: 183 -92.
    • (1991) Antiviral Res , vol.15 , pp. 183-192
    • Ito, M.1    Nakano, T.2    Kamiya, T.3
  • 3
    • 56549129228 scopus 로고    scopus 로고
    • The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: A review of the literature
    • Domm S, Cinati J, Mrowietz U,. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol 2008; 159: 1217 -28.
    • (2008) Br J Dermatol , vol.159 , pp. 1217-1228
    • Domm, S.1    Cinati, J.2    Mrowietz, U.3
  • 4
    • 71449093991 scopus 로고    scopus 로고
    • Review article: Chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
    • Shale MJ, Seow CH, Coffin CS, et al. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther 2009; 31: 20 -34.
    • (2009) Aliment Pharmacol Ther , vol.31 , pp. 20-34
    • Shale, M.J.1    Seow, C.H.2    Coffin, C.S.3
  • 5
  • 6
    • 61949188518 scopus 로고    scopus 로고
    • Development of primary varicella infection during infliximab treatment for psoriasis
    • Balato N, Gaudiello F, Balato A, et al. Development of primary varicella infection during infliximab treatment for psoriasis. J Am Acad Dermatol 2009; 60: 709 -10.
    • (2009) J Am Acad Dermatol , vol.60 , pp. 709-710
    • Balato, N.1    Gaudiello, F.2    Balato, A.3
  • 7
    • 10044224715 scopus 로고    scopus 로고
    • Disseminated primary varicella infection during infliximab treatment
    • Vonkeman H, Ten Napal C, Rasker H, et al., Disseminated primary varicella infection during infliximab treatment. J Rheumatol 2004; 31: 2517 -18.
    • (2004) J Rheumatol , vol.31 , pp. 2517-2518
    • Vonkeman, H.1    Ten Napal, C.2    Rasker, H.3
  • 8
    • 72049091520 scopus 로고    scopus 로고
    • The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease
    • Shale MJ,. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease. Br Med Bull 2009; 92: 61 -77.
    • (2009) Br Med Bull , vol.92 , pp. 61-77
    • Shale, M.J.1
  • 9
    • 77949262985 scopus 로고    scopus 로고
    • Tumour necrosis factor blockade and the risk of viral infection
    • Kim SY, Solomon DH,. Tumour necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol 2010; 6: 165 -74.
    • (2010) Nat Rev Rheumatol , vol.6 , pp. 165-174
    • Kim, S.Y.1    Solomon, D.H.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.